Clinical Trial Update: Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing interaction between the investigational drug BIA 9-1067 and standard-release levodopa/carbidopa in patients with Parkins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067
• Levodopa/Carbidopa (levodopa/carbidopa)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-12-22